Tc Biopharm PLC Stock Forecast, Predictions & Price Target

Analyst price target for TCBP

Based on 1 analyst offering 12 month price targets for Tc Biopharm PLC.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell TCBP stock?

Based on 1 analyst offering ratings for Tc Biopharm PLC.
Strong Buy
0 analysts 0%
1 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TCBP stock forecasts and price targets.

TCBP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 5%

1 of 1

TCBP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GLMD$0.58$4.00+586.11%Strong Buy

Tc Biopharm Stock Forecast FAQ

Is Tc Biopharm Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TCBP) stock is to Buy TCBP stock.

Out of 1 analyst, 0 (0%) are recommending TCBP as a Strong Buy, 1 (100%) are recommending TCBP as a Buy, 0 (0%) are recommending TCBP as a Hold, 0 (0%) are recommending TCBP as a Sell, and 0 (0%) are recommending TCBP as a Strong Sell.

If you're new to stock investing, here's how to buy Tc Biopharm stock.

What is TCBP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TCBP price target, the average TCBP price target is $7.00, with the highest TCBP stock price forecast at $7.00 and the lowest TCBP stock price forecast at $7.00.

The Wall Street analyst predicted that Tc Biopharm's share price could reach $7.00 by Apr 27, 2024. The average Tc Biopharm stock price prediction forecasts a potential upside of 1,718.18% from the current TCBP share price of $0.39.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.